Table 3.
Patients (%) without | Patients (%) with | ||
---|---|---|---|
Variable | Malignant Symptoms | Malignant Symptoms | P Value |
Flecainide left‐sided leads | |||
No | 8(42.1%) | 2(10.5%) | |
Yes | 6(31.5%) | 3(15.7%) | 0.628 |
Flecainide one space upper | |||
No | 10(52.6%) | 1(5.2%) | |
Yes | 4(21%) | 4(21%) | 0.111 |
Flecainide right‐sided leads | |||
No | 13(68.4%) | 2(10.5%) | |
Yes | 1(5.2%) | 3(15.7%) | 0.037 |
ICD Implanted | |||
No | 10(52.6%) | 0 | |
Yes | 4(21%) | 5(26.3%) | 0.011 |
Positive family history of SCD | |||
No | 10(52.6%) | 4(21%) | |
Yes | 4(21%) | 1(5.2%) | 1.00 |
Positive SCN5A | |||
No | 12(63.1%) | 3(15.7%) | |
Yes | 2(10.5%) | 2(10.5%) | 0.486 |
Total | 14(83.7%) | 5(26.3%) |